3625 results for «463»

Filter By

3625 results

Outcome of women in different cardiovascular interventions

06 Oct 2022 – From AICT-AsiaPCR 2022

AICT-AsiaPCR 2023 Opening Ceremony

21 Sep 2023 – From AICT-AsiaPCR 2023

This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...

AICT-AsiaPCR 2023 Opening Ceremony

Calcified lesions: LIVE Educational Case from Cardiac Vascular Sentral - Kuala Lumpur, Malaysia

11 Oct 2025 – From AICT-AsiaPCR 2025

This live educational session focuses on the management of calcified left main bifurcation lesions, emphasizing the critical role of intravascular imaging for procedural planning and optimization. It highlights the use of mechanical lithoplasty for calcium modification prior to stent implantation and outlines strategic considerations for successful...

Calcified lesions: LIVE Educational Case from Cardiac Vascular Sentral - Kuala Lumpur, Malaysia

COVID-19: changing perspectives in the cathlab

10 Mar 2020

"As physicians, we are experiencing a complex era that will surely impact our future way of conceiving our profession". Luigi Biasco, interventional cardiologist in Turin, Italy, shares his personal and a professional perspective on how the outbreak of the novel Coronavirus has changed life in the...

Luigi Biasco

Author

Luigi Biasco
COVID-19: changing perspectives in the cathlab

Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial

29 Mar 2025

Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author

Ali Nazmi Calik
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
Didn’t find what you were looking for?